Results 61 to 70 of about 7,771 (181)

Torsade de Pointes Induced by Hypokalemia from Imipenem and Piperacillin

open access: yesCase Reports in Cardiology, 2017
Imipenem-cilastatin and piperacillin-tazobactam are two antibiotics with broad antimicrobial coverage. Besides the many well established adverse effects of these drugs, there have been few case reports of hypokalemia.
Varun Kumar   +2 more
doaj   +1 more source

Diltiazem N‐oxide, a novel ischaemia‐activated prodrug, prevents ischaemia‐induced ventricular fibrillation without off‐target adverse effects

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 16, Page 4646-4662, August 2026.
Abstract Background and Purpose Ventricular fibrillation (VF) in coronary heart disease accounts for up to 70% of sudden cardiac death. We examined whether diltiazem N‐oxide (DNO) has ischaemia‐selective antiarrhythmic activity. Experimental Approach Randomised and blinded experiments were performed in rat isolated hearts and in anaesthetised rats to ...
Louise M. Hesketh   +5 more
wiley   +1 more source

Methadone-induced Torsades de Pointes Masquerading as Seizures

open access: yesClinical Practice and Cases in Emergency Medicine, 2017
The authors herein present the case of a 53-year-old female who was being treated as an outpatient for seizure disorder but was also receiving high-dose methadone therapy.
David C. Traficante   +2 more
doaj   +1 more source

Effects of pH on Nifekalant-Induced Electrophysiological Change Assessed in the Langendorff Heart Model of Guinea Pigs

open access: yesJournal of Pharmacological Sciences, 2014
Since information regarding the effects of pH on the extent of nifekalant-induced repolarization delay and torsades de pointes remains limited, we assessed it with a Langendorff heart model of guinea pigs.
Katsuyuki Kazusa   +4 more
doaj   +1 more source

Flecainide associated torsade de pointes: A potential case of reverse use dependence

open access: yesJournal of Research in Medical Sciences, 2013
Flecainide has been known to cause torsades de pointes (TdP) in patients with structural heart disease and its mechanism has been attributed to use-dependency.
Kevin Hayes   +5 more
doaj  

Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study

open access: yesDrug, Healthcare and Patient Safety, 2011
Matthew J Hafermann1, Rocsanna Namdar2, Gretchen E Seibold2,3, Robert Lee Page 2nd2,31University of Washington Medical Center, Department of Pharmacy, Seattle, WA; 2University of Colorado Anschutz Medical Campus, School of Pharmacy, Aurora, CO ...
Hafermann MJ   +3 more
doaj  

TORSADES DE POINTES IN A PATIENT WITH HIV WHO ABANDONED TREATMENT: AN ATYPICAL PRESENTATION

open access: yesBrazilian Journal of Infectious Diseases
Introduction: Torsades de Pointes (TdP) is a rare but potentially fatal form of polymorphic ventricular tachycardia associated with QT interval prolongation, with an estimated annual incidence of 0.16% and mortality of up to 20%.
Matheus da Silva Raetano   +4 more
doaj   +1 more source

Dilated Cardiomyopathy Compatible With Sarcoidosis Presenting with Syncope Due to Torsades de Pointes: a Case Report

open access: yesJournal of Cardiac Arrhythmias, 2020
Sarcoidosis is a multisystemic noncaseating granulomatous disease of unknown etiology. Cardiac sarcoidosis clinical presentation is diverse, and syncope is one of the possible primary events.
Carollina Fernandes Tinoco   +4 more
doaj  

Síndrome de QT largo y torsades de pointes tras la administración de levofloxacino

open access: yesRevista Cubana de Cardiología y Cirugía Cardiovascular, 2013
Aunque hay fármacos que producen una mínima prolongación del intervalo QT, éstos pueden inducir arritmias en combinación con otros que también prolonguen el intervalo QT o interfieran en su degradación.
Ignacio González Almarcegui   +5 more
doaj  

Home - About - Disclaimer - Privacy